FYI: Recent advances in biotechnology, from data-driven diagnostics to game-changing gene therapies, suggest we’re on the cusp of a golden age in which many feared diseases will become treatable, or even cured. Yet for all the optimism in the lab, pessimism reigns on Wall Street, where investors lately have been yanking money from health-care and biotech stocks and funds. Given a 25% slide in the Nasdaq Biotechnology Index from its mid-2015 peak, the disconnect between a looming scientific revolution and investors’ disillusion has grown too big to ignore.
Regards,
Ted
https://www.barrons.com/articles/the-future-of-biotech-how-to-invest-in-tomorrows-winners-51569634750?mod=past_editions
